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Chromatin transcription: Clearing the gridlock
E. Peter Geiduschek
A factor has been purified that specifically facilitates RNA
chain elongation in a chromatin context; the properties of
this factor help to define the challenges that lie ahead in
understanding how RNA polymerase manages to
transcribe DNA that is packaged into chromatin.
Address: Department of Biology and Center for Molecular Genetics,
University of California, San Diego, 9500 Gilman Drive, La Jolla,
California 92093-0634. USA. 
E-mail: epg@jbiomail.ucsd.edu
Current Biology 1998, 8:R373–R375
http://biomednet.com/elecref/09609822008R0373
© Current Biology Ltd ISSN 0960-9822
Making a faithful and full-length RNA transcript of a
double-stranded DNA template is a complex task, largely
because of the requirement for processivity and retention
of register during RNA chain elongation. Dispersal of the
polymerase and its nascent transcript into the three-
dimensional space of the cell is effectively irreversible,
and must therefore be prevented from occurring (although
displacement in the one-dimensional space of the DNA
thread is reversible and therefore tolerable) [1,2]. The
nascent RNA chain must also be held in the transcription
complex in such a way that the register between transcript
and template is retained, even in the face of repetitive
DNA sequences. Nevertheless, it is also necessary to be
able to abandon processivity on cue, that is, upon
encounter of DNA sequences or DNA-bound proteins
signaling termination of transcription [2,3].
DNA-dependent RNA polymerases are adapted to these
requirements, and to functioning in concert with protein
factors and RNA structures to make the RNA chain
elongation and termination part of the regulation of gene
activity. In bacteria (Escherichia coli, that is), RNA chain
elongation is modulated by a number of accessory proteins,
including ρ, NusA, NusB, NusG, NusE (S10 ribosomal
protein), GroA and GroB. Bacterial RNA chain elongation
responds to diverse cellular regulators, including the
Figure 1
Facts about the action of FACT. The
transcription template with its GAL4-binding
upstream activation sites, transcriptional start
site and 390 base pair G-less sequence, is
sketched at the top. The lengths of G-less
transcripts generated under different
conditions with and without FACT are
indicated below.
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translational machinery and nucleotide-generating, as well
as nucleotide-consuming, metabolism. A number of viral
regulatory proteins, of which phage λ, N and Q proteins
are the best-studied examples, also modulate RNA chain
elongation as well as termination [3–5].
The expectation that RNA chain elongation in eukaryotes
cannot be any less complex than it is in bacteria is in the
process of more than ample fulfillment. The currently iden-
tified transcript elongation factors of RNA polymerase II
include TFIIF, SII (the functional homologue of the bacte-
rial GreB and GreA proteins), SIII/elongin, ELL, P-TEFb
(‘positive transcription elongation factor’), and the transcript
release factor-2 [3,6]. What all these factors have in common
is that they have been identified through biochemical
analysis of transcription of naked DNA templates. In cells,
however, transcription by polymerase II takes place in the
confining context of chromatin [7–9]. The special interest
of a recent paper by Orphanides et al. [10] is that it docu-
ments the identification and purification from human cells
of a two-protein complex, FACT, which facilitates RNA
chain elongation by human polymerase II specifically on a
chromatin template (hence the acronym, for a transcription
component that ‘facilitates chromatin transcription’).
The basic observations leading to the search for FACT
(Figure 1) involved in vitro transcription of DNA containing
GAL4-binding sites upstream of a polymerase II promoter
linked to a transcription unit consisting of an approximately
400 base pair ‘G-less cassette’ (DNA designed to be tran-
scribed with ATP, CTP and UTP only). A crude Drosophila
embryo extract assembles this DNA into nucleosome arrays
that are regularly spaced in the manner of natural chro-
matin. In the presence of ATP, the Drosophila extract mobi-
lizes and ultimately remodels this chromatin around the
transcriptional activator GAL4–VP16 — a fusion protein
consisting of the DNA-binding domain of yeast GAL4
linked to the activation domain of the viral protein VP16 —
in such a way that the promoter becomes accessible to the
transcription machinery (Figure 2a, top line). 
As is already well known, transcription of this chromatin-
loaded DNA with a crude nuclear extract from HeLa
(human) cells absolutely requires the transcriptional
activator GAL4–VP16. The key result was obtained
when, instead of using the crude HeLa system, the
experiment was repeated with purified polymerase II
general transcription factors (TFIIB, TFIID, TFIIE,
TFIIF, TFIIH and TFIIA), the activator-responsive
factor PC-4 and polymerase II. It is well known that
naked DNA is transcribed by this combination of compo-
nents, and that this transcription is activated by
GAL4–VP16. But chromatin did not yield the anticipated
transcripts. Why not? 
It turns out that, in the experimental set-up employed by
Orphanides et al. [10], polymerase II does get recruited to
the promoter, which opens as normal, allowing short tran-
scripts to be formed on the chromatin template by the
purified, simplified and reconstituted transcription system.
But the polymerase gets stuck when the nascent RNA
chains reach lengths of approximately 20–60 nucleotides.
Orphanides et al. [10] then fractionated the HeLa cell
nuclear extract to find the activity that allows polymerase
II to elongate transcripts on a chromatin template. In this
way, they purified FACT, the factor that counteracts the
chromatin-mediated block to transcript elongation. 
FACT was found to consist of two co-purifying proteins,
of molecular weights approximately 140 kDa and 80 kDa.
FACT acts purely to permit transcript elongation, without
apparently interacting with the transcriptional activator. It
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Figure 2
(a) An interpretation of the findings
summarized in Figure 1. Chromatin
remodeling factors are required to provide
access for transcription factors and the
polymerase II transcription machinery to the
promoter and its conjugate activation sites
(top). FACT, possibly in conjunction with other
components, is required to allow elongation of
transcripts through nucleosome arrays.
(Adapted from [10].) Histone octamers are
represented as disks. (b) A possible
mechanism for nucleosome displacement by
the RNA chain-elongating polymerase. The
DNA originally assembled into a nucleosome
and displaced by the advancing polymerase is
shown in blue. (Adapted from [11,12].)
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does not require ATP hydrolysis for its action, nor does it
require the TFIIF and TFIIS elongation factors as co-
effectors. Because its activation is effectively competed by
naked DNA, FACT is thought to be a DNA-binding
protein. Orphanides et al. [10] hazard the guess that FACT
works in a stoichiometric fashion, with near-equivalence
to the nucleosomes. Its fate during transcript elongation
remains to be determined.
A technically demanding variation on these experiments
yielded a second interesting outcome. Ternary transcrip-
tion complexes with short — 15 and 18 nucleotides long
— nascent RNA chains were first formed on naked DNA,
purified and then used to assemble chromatin with
purified histones (by salt-step dilution and dialysis). It was
found that, with this highly purified chromatin and highly
purified transcription machinery, the elongation of RNA
chains is almost immediately blocked (when a mere ten or
fewer nucleotides were added to the nascent RNA
chains). FACT relieves this block also, but does not
prevent stalling further along the DNA template, when
the nascent RNA chains have advanced no more than
about 50–150 nucleotides (that is, about a nucleosome’s
worth of DNA, or less).
That FACT generates such a modest RNA extension in
conjunction with the most purified components clearly
raises the possibility that it might be specialized for
dealing only with the promoter-proximal nucleosome, or
that it might require co-factors to manifest its full range of
action. Orphanides et al. [10] also point to a mundane tech-
nical limitation of their experiment. Salt-gradient prepara-
tion of chromatin assembles nucleosomes unevenly and,
in the limit, over-packs nucleosomes on DNA. The ener-
getic cost of nucleosome displacement by RNA poly-
merase is mitigated by DNA-to-DNA nucleosome
transfer, including transfer around the advancing RNA
polymerase [11,12] (Figure 2b). Over-packing DNA with
nucleosomes may interfere with factor-facilitated RNA
chain elongation by preventing such transfer.
Although I have focused on FACT, I also want to refer the
reader to two very interesting recent reports [13,14] of evi-
dence that the budding yeast proteins Spt4 and Spt5,
which associate with polymerase II, contribute to normal
RNA chain elongation in vivo, and that their human
homologues confer sensitivity to the RNA-chain-elonga-
tion inhibitor 5,6-dichloro-1-D-ribofuranosylbenzimidazole
on transcription by polymerase II in nuclear extracts. Per-
suasive, though indirect, arguments are marshalled to
support the suggestion that these Spt proteins may play a
role in helping polymerase II to surmount obstructions —
including obstructions generated by chromatin — as it
elongates RNA chains. However, experiments on chro-
matin transcription in vitro, comparable to those described
for FACT, remain to be reported for this Spt complex.
These are fast-changing times in the quest to understand
the critical interplay of chromatin structure, plasticity and
modification with the transcription apparatus in the
control of gene activity [7–9,15]. With regard to the mech-
anism of RNA chain elongation on chromatin, one can
convey a sense of the ideals and objectives of the search
— at least from a biochemical perspective — and of the
distance not yet traveled, by specifying the ultimate
(hypothetical) in vitro reconstitution assay. This might
combine a chromatin-embedded gene of appreciable
length that responds to the various factors that work
together to promote RNA chain elongation by polymerase
II at an approximately in vivo rate (40–50 nucleotides per
second on average). These would include enzymes such as
histone acetyltransferases that modify higher-order nucle-
osome interactions; enzymes such as ATPases and protein
kinases that mobilize nucleosome transfer along DNA;
and elongation factors. Following the individual molecules
of RNA polymerase in real time as they negotiate their
nucleosome-strewn path along the gene will be especially
interesting, because it will allow us to understand how the
potential gridlock of chromatin transcription is resolved.
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